- Savara Inc at Guggenheim Healthcare Talks Biotechnology Conference TranscriptFeb 07, 2024
- Savara Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Savara Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) TranscriptSep 20, 2021
- Savara Inc Annual Shareholders Meeting TranscriptJun 10, 2021
- Q2 2020 Savara Inc Earnings Call TranscriptAug 06, 2020$2.04 (-3.77%)Earnings
- Savara Inc Annual Shareholders Meeting TranscriptMay 27, 2020
- Q1 2020 Savara Inc Earnings Call TranscriptMay 07, 2020$2.55 (+5.81%)Earnings
- Savara Inc. - Special Call TranscriptApr 03, 2020
- Q4 2019 Savara Inc Earnings Call TranscriptMar 12, 2020$2.55 (+8.05%)Earnings
- Q3 2019 Savara Inc Earnings Call TranscriptNov 07, 2019$0.91 (-1.09%)Earnings
- Q2 2019 Savara Inc Earnings Call TranscriptAug 08, 2019$2.51 (+2.03%)Earnings
- Savara Inc Announces Results of IMPALA, a Phase 3 Study of Molgradex for the Treatment of Autoimmune Alveolar Pulmonary Proteinosis (aPAP) TranscriptJun 12, 2019
- Q1 2019 Savara Inc Earnings Call TranscriptMay 09, 2019$10.72 (-2.46%)Earnings
- Q4 2018 Savara Inc Earnings Call TranscriptMar 13, 2019$8.6 (+1.30%)Earnings
Q2 2019 Savara Inc Earnings Call Transcript
Good afternoon, and welcome to the Savara Conference Call.
(Operator Instructions) An audio webcast of this call will be available on the Investors section of Savara's website at Savarapharma.com. This call is subject to copyright and is a property of Savara. All recordings, reproduction or transmission of this call without the expressed written consent of Savara is strictly prohibited. As a reminder, today's call is being recorded.
I would like to now turn the phone over to Anne Erickson, Head of Investor Relations and Corporate Communications at Savara.
Good afternoon, and thank you everyone for joining us on today's call. A press release reporting our Second Quarter 2019 Financial Results was issued earlier today, August 8, 2019, and can be found on the Investors section of our website at Savarapharma.com. If you did not received this release or if you'd like to be added to the company's distribution list, please email me at [email protected].
This call is
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)